[go: up one dir, main page]

GB201612437D0 - Anti-lag-3 antibodies - Google Patents

Anti-lag-3 antibodies

Info

Publication number
GB201612437D0
GB201612437D0 GBGB1612437.2A GB201612437A GB201612437D0 GB 201612437 D0 GB201612437 D0 GB 201612437D0 GB 201612437 A GB201612437 A GB 201612437A GB 201612437 D0 GB201612437 D0 GB 201612437D0
Authority
GB
United Kingdom
Prior art keywords
lag
antibodies
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
GBGB1612437.2A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Immutep SAS
Original Assignee
Immutep SAS
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Immutep SAS filed Critical Immutep SAS
Priority to GBGB1612437.2A priority Critical patent/GB201612437D0/en
Publication of GB201612437D0 publication Critical patent/GB201612437D0/en
Priority to EP16759785.5A priority patent/EP3344654B1/en
Priority to RU2018111508A priority patent/RU2760582C2/en
Priority to PL16759785T priority patent/PL3344654T3/en
Priority to ES16759785T priority patent/ES2842306T3/en
Priority to KR1020187008670A priority patent/KR102808640B1/en
Priority to RU2021133819A priority patent/RU2021133819A/en
Priority to JP2018511202A priority patent/JP7074341B2/en
Priority to HK18115194.2A priority patent/HK1256116B/en
Priority to SG10201913864RA priority patent/SG10201913864RA/en
Priority to MX2018002610A priority patent/MX2018002610A/en
Priority to PT167597855T priority patent/PT3344654T/en
Priority to PCT/EP2016/070664 priority patent/WO2017037203A1/en
Priority to IL257798A priority patent/IL257798B2/en
Priority to EP20197814.5A priority patent/EP3798234A1/en
Priority to CA2995639A priority patent/CA2995639A1/en
Priority to MYPI2018700711A priority patent/MY205096A/en
Priority to BR112018004181-5A priority patent/BR112018004181B1/en
Priority to CN202311238293.2A priority patent/CN117510633A/en
Priority to US15/756,767 priority patent/US11680104B2/en
Priority to KR1020257015478A priority patent/KR20250073532A/en
Priority to DK16759785.5T priority patent/DK3344654T3/en
Priority to NZ740357A priority patent/NZ740357B2/en
Priority to CN201680064139.XA priority patent/CN108699145A/en
Priority to AU2016316730A priority patent/AU2016316730B2/en
Priority to NZ779096A priority patent/NZ779096B2/en
Priority to PH12018500369A priority patent/PH12018500369A1/en
Priority to MX2023001226A priority patent/MX2023001226A/en
Priority to ZA2018/01432A priority patent/ZA201801432B/en
Priority to JP2021041608A priority patent/JP2021097706A/en
Priority to JP2022113055A priority patent/JP2022137218A/en
Priority to US18/312,629 priority patent/US20230272107A1/en
Priority to AU2023204589A priority patent/AU2023204589A1/en
Priority to JP2024092967A priority patent/JP2024116273A/en
Ceased legal-status Critical Current

Links

GBGB1612437.2A 2015-09-02 2016-07-18 Anti-lag-3 antibodies Ceased GB201612437D0 (en)

Priority Applications (34)

Application Number Priority Date Filing Date Title
GBGB1612437.2A GB201612437D0 (en) 2016-07-18 2016-07-18 Anti-lag-3 antibodies
NZ779096A NZ779096B2 (en) 2016-09-01 Anti-LAG-3 Antibodies
MYPI2018700711A MY205096A (en) 2015-09-02 2016-09-01 Anti-lag-3 antibodies
BR112018004181-5A BR112018004181B1 (en) 2015-09-02 2016-09-01 Anti-LAG-3 antibodies, nucleic acid, recombinant vector, pharmaceutical composition comprising the anti-LAG-3 antibody and its use.
PL16759785T PL3344654T3 (en) 2015-09-02 2016-09-01 ANTI-LAG-3 ANTIBODIES
ES16759785T ES2842306T3 (en) 2015-09-02 2016-09-01 Anti LAG-3 antibodies
KR1020187008670A KR102808640B1 (en) 2015-09-02 2016-09-01 Anti-LAG-3 antibody
RU2021133819A RU2021133819A (en) 2015-09-02 2016-09-01 ANTI-LAG-3 ANTIBODIES
JP2018511202A JP7074341B2 (en) 2015-09-02 2016-09-01 Anti-LAG-3 antibody
HK18115194.2A HK1256116B (en) 2015-09-02 2016-09-01 Anti-lag-3 antibodies
SG10201913864RA SG10201913864RA (en) 2015-09-02 2016-09-01 Anti-LAG-3 Antibodies
MX2018002610A MX2018002610A (en) 2015-09-02 2016-09-01 ANTI-LAG-3 ANTIBODIES.
US15/756,767 US11680104B2 (en) 2015-09-02 2016-09-01 Anti-LAG-3 antibodies
PCT/EP2016/070664 WO2017037203A1 (en) 2015-09-02 2016-09-01 Anti-LAG-3 Antibodies
IL257798A IL257798B2 (en) 2015-09-02 2016-09-01 Anti-lag-3 antibodies
EP20197814.5A EP3798234A1 (en) 2015-09-02 2016-09-01 Anti-lag-3 agonistic antibodies
CA2995639A CA2995639A1 (en) 2015-09-02 2016-09-01 Anti-lag-3 antibodies
EP16759785.5A EP3344654B1 (en) 2015-09-02 2016-09-01 Anti-lag-3 antibodies
CN202311238293.2A CN117510633A (en) 2015-09-02 2016-09-01 anti-LAG-3 antibody
RU2018111508A RU2760582C2 (en) 2015-09-02 2016-09-01 Anti-lag-3 antibodies
PT167597855T PT3344654T (en) 2015-09-02 2016-09-01 ANTI-LAG-3 ANTIBODIES
KR1020257015478A KR20250073532A (en) 2015-09-02 2016-09-01 Anti-LAG-3 Antibodies
DK16759785.5T DK3344654T3 (en) 2015-09-02 2016-09-01 ANTI-LAG-3 ANTIBODIES
NZ740357A NZ740357B2 (en) 2016-09-01 Anti-LAG-3 Antibodies
CN201680064139.XA CN108699145A (en) 2015-09-02 2016-09-01 anti-LAG-3 antibody
AU2016316730A AU2016316730B2 (en) 2015-09-02 2016-09-01 Anti-LAG-3 Antibodies
PH12018500369A PH12018500369A1 (en) 2015-09-02 2018-02-19 Anti-lag-3 antibodies
MX2023001226A MX2023001226A (en) 2015-09-02 2018-03-01 Anti-LAG-3 Antibodies.
ZA2018/01432A ZA201801432B (en) 2015-09-02 2018-03-01 Anti¿lag¿3 antibodies
JP2021041608A JP2021097706A (en) 2015-09-02 2021-03-15 Anti-lag-3 antibodies
JP2022113055A JP2022137218A (en) 2015-09-02 2022-07-14 Anti-lag-3 antibodies
US18/312,629 US20230272107A1 (en) 2015-09-02 2023-05-05 Anti-lag-3 antibodies
AU2023204589A AU2023204589A1 (en) 2015-09-02 2023-07-11 Anti-lag-3 antibodies
JP2024092967A JP2024116273A (en) 2015-09-02 2024-06-07 Anti-LAG-3 antibody

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GBGB1612437.2A GB201612437D0 (en) 2016-07-18 2016-07-18 Anti-lag-3 antibodies

Publications (1)

Publication Number Publication Date
GB201612437D0 true GB201612437D0 (en) 2016-08-31

Family

ID=56890565

Family Applications (1)

Application Number Title Priority Date Filing Date
GBGB1612437.2A Ceased GB201612437D0 (en) 2015-09-02 2016-07-18 Anti-lag-3 antibodies

Country Status (1)

Country Link
GB (1) GB201612437D0 (en)

Similar Documents

Publication Publication Date Title
ZA201900373B (en) Anti-tim-3 antibodies
IL259048A (en) Anti-ror1 antibodies
SG10201601719RA (en) Anti-LAG-3 Antibodies
GB201601073D0 (en) Antibodies
SG10201913864RA (en) Anti-LAG-3 Antibodies
GB201621439D0 (en) IL-11Ra Antibodies
IL253633B (en) Anti-transthyretin antibodies
GB201521393D0 (en) Antibodies
GB201521391D0 (en) Antibodies
GB201610044D0 (en) Antibodies
PL3250593T3 (en) Anti-transthyretin antibodies
SG10202010735PA (en) Tau-binding antibodies
GB201521382D0 (en) Antibodies
IL255323A0 (en) Anti-fcrn antibodies
GB201616699D0 (en) Antibodies
ZA201808317B (en) Anti-tnfrsf25 antibodies
GB201603291D0 (en) Antibodies
PT3484921T (en) Anti-il-22r antibodies
IL260083B1 (en) Anti-myl9 antibody
GB201509907D0 (en) Antibodies
GB201522394D0 (en) Antibodies
GB201503438D0 (en) Antibodies
IL284022A (en) Anti-transthyretin antibodies
GB201622197D0 (en) Antibodies
GB201620414D0 (en) Antibodies

Legal Events

Date Code Title Description
AT Applications terminated before publication under section 16(1)